CFU-GEMM

ILiAD Biotechnologies Reports First-ever Demonstration of Protection Against B. pertussis Colonization in Phase 2b Human Challenge Study of BPZE1 Vaccine

Retrieved on: 
Tuesday, September 5, 2023
Other Health, Research, General Health, Pharmaceutical, Infectious Diseases, Hospitals, Clinical Trials, Science, Biotechnology, FDA, Other Science, Health, Vaccine, Bordetella pertussis, Cold medicine, University Hospital Southampton NHS Foundation Trust, University, Vaccination, Culture, Public, Immunity, Infection, CFU, CDC, Epidemic, Quarantine, Death, Congress, Professor, CFU-GEMM, Clutch (eggs), United Kingdom, Iliad, Immunization, University of Oxford, Safety, Disease, MD

ILiAD Biotechnologies reported today that its BPZE1 intranasal pertussis vaccine has met the primary endpoint of protection against nasopharyngeal B. pertussis colonization (p=0.03) in the Phase 2b CHAMPION-1 Study.

Key Points: 
  • ILiAD Biotechnologies reported today that its BPZE1 intranasal pertussis vaccine has met the primary endpoint of protection against nasopharyngeal B. pertussis colonization (p=0.03) in the Phase 2b CHAMPION-1 Study.
  • The CHAMPION-1 Phase 2b Human Challenge study is a randomized, double-blind, placebo-controlled study of BPZE1 vaccine in healthy adults.
  • The study has a primary objective to demonstrate that prior immunization with BPZE1 protects against colonization as evidenced by negative B. pertussis culture following virulent B. pertussis challenge 2–4 months after vaccination.
  • As a result, the preparation method of the B. pertussis challenge dose was modified to achieve the per-protocol adequate inoculum of B. pertussis challenge as specified in the original study protocol.

Hyperbiotics Launches PRO-IBS Support* Premium Precision Probiotic Formula

Retrieved on: 
Thursday, August 10, 2023
Shellfish, Prevalence, Boswellia serrata, Doctor of Philosophy, Patient, IBS, Gastroenterology, CFU-GEMM, The Non-GMO Project, Bloating, Diagnosis, American College, Probiotic, Allergen, Support, Dietary supplement, Lactiplantibacillus

MIDDLETOWN, Conn., Aug. 10, 2023 /PRNewswire/ -- Hyperbiotics, a global leader in precision probiotics, today announced the launch of PRO-IBS Support*, an advanced, dual-action synergistic blend of Lactiplantibacillus plantarum 299v and the highly bioavailable Boswellia serrata extract. This unique combination formula was designed to effectively stabilize gut discomfort and dysfunction in patients with IBS, and provide accelerated and prolonged relief from bloating, gas, and irregularity.*

Key Points: 
  • MIDDLETOWN, Conn., Aug. 10, 2023 /PRNewswire/ -- Hyperbiotics, a global leader in precision probiotics, today announced the launch of PRO-IBS Support *, an advanced, dual-action synergistic blend of Lactiplantibacillus plantarum 299v and the highly bioavailable Boswellia serrata extract.
  • This unique combination formula was designed to effectively stabilize gut discomfort and dysfunction in patients with IBS, and provide accelerated and prolonged relief from bloating, gas, and irregularity.
  • *
    According to the American College of Gastroenterology, an estimated 10-15% of the adult population in the United States have irritable bowel syndrome (IBS), but only 5-7% receive an IBS diagnosis.
  • Hyperbiotics offers a comprehensive line of precision probiotics – harnessing science-backed probiotic strains to deliver probiotics tailored to patient needs, at an affordable price point.

Keep Your Dog Cool and Healthy This Summer With Ultimate Pet Nutrition Nutra Thrive for Dogs

Retrieved on: 
Friday, August 4, 2023
Well, Selenium, Mineral, Food, Zinc, Dog, Dehydration, Digestion, Magnesium, Riboflavin, Ultimate (Pet Shop Boys album), Heat exhaustion, Ageing, Nutrient, Immunity, Dietary fiber, Calcium, Heat, Vitamin, Folate, Fresh water, CFU-GEMM, Joint, LOS, Health, Potassium, Probiotic, Antioxidant, Animal feed, Lipase, Papain

LOS ANGELES, Aug. 4, 2023 /PRNewswire/ -- During the summer, it is crucial to keep your dog cool and healthy to ensure its overall well-being. High temperatures can pose significant risks to our furry companions, leading to heat exhaustion, dehydration, and potential heatstroke. World-renowned veterinarian, Dr. Gary Richter, recommends keeping them cool by providing ample shade and fresh water, limiting outdoor activities during peak heat, and providing your dog with a supplement to help ensure they replenish all their nutrients.

Key Points: 
  • Enhance Your Dog's Well-Being and Health with the Award-Winning, Ultimate Pet Nutrition Nutra Thrive For Dogs Nutritional Supplement
    LOS ANGELES, Aug. 4, 2023 /PRNewswire/ -- During the summer, it is crucial to keep your dog cool and healthy to ensure its overall well-being.
  • Award-winning canine nutritional supplement, Ultimate Pet Nutrition® Nutra Thrive is the perfect way to support your dog's health this summer.
  • Ultimate Pet Nutrition Nutra Thrive was awarded the prestigious Pet Innovation Award in 2022 for being the best "Dog Vitamin/Supplement of the Year."
  • Ultimate Pet Nutrition Nutra Thrive for Dogs is a groundbreaking bacon-flavored canine supplement, designed with a potent 4-in-1 blend to elevate the nutritional value of any dog food.

Blueshift Nutrition Elevates Supplement Game with Delicious Flavors - Now on Amazon

Retrieved on: 
Tuesday, May 9, 2023
Taste, Focus, Nutrition, Overalls, Coronavirus Scientific Advisory Board, Palate, Plant, IPA, Immune system, CFU-GEMM, Coffee, Health, Probiotic, Dietary supplement, Soft drink, Redshift, Amazon, Food

BOSTON, May 9, 2023 /PRNewswire/ -- Now available on Amazon, Blueshift Nutrition's lineup of Superblend supplement drinks applies the principles of mixology to transform the experience of taking supplements from a chore to a delight. The company's proprietary FlavorWeaving approach utilizes the complex flavor notes of botanicals, fruits, berries and other active ingredients as a source of complexity and interest instead of masking them with added sugar, artificial sweeteners, or other junk ingredients.

Key Points: 
  • Blueshift Nutrition's proprietary FlavorWeaving approach harnesses the complex flavors of phytonutrient-rich botanicals to craft supplement drinks as delicious as they are effective.
  • "But when you think about the beverages people love most – coffee, red wine, IPA beer – they aren't loved for being sweet.
  • Blueshift doesn't just care about offering craveable flavors; they've invested years into developing some of the most effective formulations on the market.
  • Blueshift is launching on Amazon with three of their best-selling Superblends: Energy + Focus, Immune Ultra, and Pre + Probiotic Ultra.

When It Comes to Probiotics for Women, Gut Health Is Just the Beginning.

Retrieved on: 
Wednesday, May 3, 2023
Vagina, Learning, Diet, Powder, Probiotic, Benefit, Anatomy, Infection, Lactobacillus acidophilus, Woman, Research, Doctor of Philosophy, CFU, Science, Nutritional science, Capsule, International Food Information Council, Patient, CFU-GEMM, Menopause, Biology, Entrepreneurship, GI, System, Prebiotic (nutrition), Female, Birth control, Dietary supplement, Gum arabic, The New York Times, Lactobacillus, Urology, Amazon, MD

ATLANTA, May 3, 2023 /PRNewswire/ -- Approximately 33% of Americans take probiotics in some form, such as capsules, powders, foods, or drinks,2 a number that reportedly increases each year. According to the International Food Information Council's 2022 Gut Health and Probiotics Survey, the top reason why survey-takers consume probiotics is to support their gut health.3 But when it comes to women's biology, the gut is only one-third of the equation.

Key Points: 
  • According to the International Food Information Council's 2022 Gut Health and Probiotics Survey, the top reason why survey-takers consume probiotics is to support their gut health.3 But when it comes to women's biology, the gut is only one-third of the equation.
  • With women's anatomy, the three parts of the female pelvic triangle—the gut, vagina, and urinary tract—are intrinsically connected, and need to be considered holistically.
  • Because probiotics are living microorganisms, it's expected that some will die before you have a chance to ingest them.
  • (2022) Consumer Insights on Gut Health and Probiotics.

PULP CULTURE AND THE EVERY COMPANY LAUNCH WORLD'S FIRST PROTEIN-BOOSTED HARD JUICE

Retrieved on: 
Wednesday, October 12, 2022
LinkedIn, Milk, Ingredient, SRP, Nutrient, Food technology, Future, Energy drink, Science, Bev, CFU-GEMM, Animal, Taste, Egg white, Clara Foods, CAGR, Solubility, Hemoprotein, Calcium, Drink, Fungus, Instagram, Vanilla, Entrepreneurship, Adaptogen, Culture, BUILD, Ironman, Partnership, Technology, AB InBev, Region, LOS, Pulp, Probiotic, Immune system, Meat, Full Spectrum, CEO, Complementarity, Brazier, Season, Fermentation, Vitamin D, Cordyceps, Alcoholism, USD, Protein, Dietary supplement, Coffee, Wine, Bacteria

LOS ANGELES, Oct. 12, 2022 /PRNewswire/ -- Pulp Culture, the acclaimed better-for-you bev-alc innovator, today announces an expansion of its category-defining lineup with the release of "BUILD," the world's first protein-boosted hard juice. A super beverage developed with leading alternative protein player The EVERY Co. ("EVERY"), BUILD (SRP $16.99/4 pack) is the first release in the new hyper-functional Pulp Culture+ line, now nationally available online while supplies last, with brick and mortar retail roll-out to follow.

Key Points: 
  • Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9072251-pulp-culture-the-every-c...
    BUILD by Pulp Culture+ represents a breakthrough in functional beverages: a protein-boosted, Full Spectrum alcoholic beverage that actually tastes good.
  • "We know people, especially fitness enthusiasts, want the positive outcomes of a better beverage that naturally contains alcoholand it's finally here."
  • EVERY Protein's superior performance among leading soluble proteins finally unlocked this super beverage from Pulp Culture, which required zero masking agents, sugar or other unnecessary additives to create its first-to-market, protein-boosted hard juice.
  • BUILD by Pulp Culture+ is available for purchase online at PulpCulture.la/products/BUILD, beginning today, October 12, 2022, while supplies last.

Novome Biotechnologies Raises $43.5 Million Series B Financing to Advance its Pipeline of Therapeutically Engineered Microbes

Retrieved on: 
Tuesday, September 13, 2022
Therapy, Gastrointestinal tract, Safety, Chronic kidney disease, University of Minnesota, Metabolic disorder, Risk, FDA, Prevalence, Inflammatory bowel disease, ID, CKD, Investment, CFU-GEMM, Survival, Kidney, Clinical trial, CEO, Alta Partners, Protein, Bacteria, Tencent, Bariatric surgery, SAN, Hyperoxaluria, Biotechnology, IBD, GLOBE, Kidney stone disease, University, Genentech, Absorption, Disease, Conditional sentence, Pharmaceutical industry, Vaccine, Novomer, Patient

SOUTH SAN FRANCISCO, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Novome Biotechnologies, Inc., a biotechnology company engineering first-in-class, living medicines for chronic diseases, today announced the close of a $43.5 million Series B financing. The financing was led by Tencent, and includes new investors University of Minnesota, Navian Investments, Colorcon Ventures and Touchdown Ventures. Existing investors DCVC Bio, 5AM Ventures, Alta Partners and Alexandria Venture Investments also participated in the financing.

Key Points: 
  • The financing was led by Tencent, and includes new investors University of Minnesota, Navian Investments, Colorcon Ventures and Touchdown Ventures.
  • "Novome's recent accomplishments and this new funding should further advance and validate our platform's capabilities and unlock additional pipeline opportunities.
  • I am grateful for the strong support of new and current investors who share our vision of developing first-in-class therapeutically engineered gut microbes.
  • Novome Biotechnologies is a clinical-stage biotechnology company developing engineered cellular therapies for the gut to treat chronic diseases.

New Research Reveals Just How Many Germs Kids Bring Home from School

Retrieved on: 
Monday, August 22, 2022
People, National Science Foundation, Public health, NYSE, Research, Schlesinger Group, MOE, Solution, CFU-GEMM, St. Chux Derby Chix, Parent, NSF International, Multimedia, CLX, Bee, Burt's Bees, Millennials, National Science Foundation: Under the Microscope, Color, ESG, Marketing, POC, Bacteria, Child, Cereal, Toy, Residential care, Tutoring, Clorox

OAKLAND, Calif., Aug. 22, 2022 /PRNewswire/ -- The first day of school is go-time for parents, but it's also go-time for germs. New research from the Clorox® brand found that the clothes kids wore to school came back 28 times germier than the average toilet seat.1 What's more, the study found kids' backpacks are often the most neglected by parents when it comes to sanitization, and it shows. On average, kids' backpacks clocked in 31 times germier than the average cell phone.1

Key Points: 
  • On average, kids' backpacks clocked in 31 times germier than the average cell phone.1
    These germs can stop families in their tracks, but parents can't afford to be slowed down.
  • By adopting a holistic germ-prevention strategy, parents can help prevent the spread of illness-causing germs on surfaces.
  • Together, they're helping to educate parents on germ spread in order to help keep households running smoothly for an unstoppable year ahead.
  • More than two-thirds (69%) of parents are concerned about their children bringing germs home from school and more than half (54%) expect their kids to get them sick.

Amba® Products Releases Study on Reduced Bacterial Growth on Heated Towels

Retrieved on: 
Thursday, August 11, 2022
Bacteria, Infection, Skin, African Journal of Infectious Diseases, Efficacy, Perception, African Journal, CFU-GEMM, Growth, Tissue paper, Linens

ATLANTA, Aug. 11, 2022 /PRNewswire-PRWeb/ -- Amba Products (Amba), the nation's largest supplier of heated towel racks, has conducted and recently released a third-party study by EMSL Analytical Inc testing on the Efficacy of a Heated Towel Rack to Reduce Bacterial Growth on Towels Under Daily Wetting Conditions.

Key Points: 
  • Amba Products (Amba), the nation's largest supplier of heated towel racks, has conducted and recently released a third-party study by EMSL Analytical Inc testing on the Efficacy of a Heated Towel Rack to Reduce Bacterial Growth on Towels Under Daily Wetting Conditions.
  • According to the study, the results show that the growth of bacteria is significantly reduced on heat-dried towels.
  • ATLANTA, Aug. 11, 2022 /PRNewswire-PRWeb/ -- Amba Products (Amba), the nation's largest supplier of heated towel racks, has conducted and recently released a third-party study by EMSL Analytical Inc testing on the Efficacy of a Heated Towel Rack to Reduce Bacterial Growth on Towels Under Daily Wetting Conditions.
  • According to the study, the results show that the growth of bacteria is significantly reduced on heat dried towels.

Presentations at ASM Microbe Conference Demonstrate Potential of ContraFect’s Direct Lytic Agents (DLAs) to Address MRSA Infections

Retrieved on: 
Tuesday, June 14, 2022
Bloodstream infections, Subclinical infection, Campaign, Breakthrough therapy, Death, Pseudomonas aeruginosa, Șaeș, Vancomycin, Pneumonia, Conference, HHS, Forward-looking statement, CEO, Lysin, Security (finance), Staphylococcus, Hypersensitivity, U.S. Securities and Exchange Commission, Oxacillin, Nasdaq, Maintenance, Endocarditis, Enterobacter, Rockefeller University, DLA, FDA, GLOBE, MSSA, Patient, Mortality, BSI PAS 2060, Biofilm, BARDA, Daptomycin, Trial of the century, Methicillin-resistant Staphylococcus aureus, Acinetobacter baumannii, Clinical trial, ASPR, CFU, Infection, SOC, MRSA, CFU-GEMM, MIC, Osteomyelitis, Bacteria, S. aureus, Peptide, Antibiotics, Pharmaceutical industry

These data were recently presented at the ASM Microbe Conference held in Washington, D.C. from June 9-13, 2022.

Key Points: 
  • These data were recently presented at the ASM Microbe Conference held in Washington, D.C. from June 9-13, 2022.
  • These results demonstrate that lysins offer a potentially effective strategy for treating implant-associated MRSA osteomyelitis infections.
  • These in vitro studies demonstrate the low propensity for the development of resistance to exebacase in both MRSA and methicillin-sensitive S. aureus (MSSA) strains.
  • 28-day serial passage resistance assays demonstrated that the minimum inhibitory concentration (MIC) of exebacase was not increased against MRSA and MSSA.